These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12139674)

  • 61. [Value of hematopoietic stem cell autotransplantation in the treatment of multiple myeloma: initial experience at the National Bone Marrow Transplantation Center and review of the literature].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2000 Oct; 78(10):548-56. PubMed ID: 11190737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.
    Nath CE; Shaw PJ; Trotman J; Zeng L
    Bone Marrow Transplant; 2007 Oct; 40(7):707-8. PubMed ID: 17680022
    [No Abstract]   [Full Text] [Related]  

  • 63. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
    Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
    Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
    [No Abstract]   [Full Text] [Related]  

  • 64. Oligoclonal reconstitution masquerading as myeloma relapse.
    Chim CS; Chan EY
    Ann Hematol; 2013 Jun; 92(6):847-8. PubMed ID: 23150202
    [No Abstract]   [Full Text] [Related]  

  • 65. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
    Larsson K; Björkstrand B; Ljungman P
    Support Care Cancer; 1998 Jul; 6(4):378-83. PubMed ID: 9695206
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells.
    Khan SA; Moreb JS
    Bone Marrow Transplant; 2005 Aug; 36(3):267-8. PubMed ID: 15937501
    [No Abstract]   [Full Text] [Related]  

  • 67. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
    Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
    Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.
    Björkstrand B; Ljungman P; Bird JM; Samson D; Gahrton G
    Bone Marrow Transplant; 1995 Mar; 15(3):367-71. PubMed ID: 7599560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The use of an expanded circulating hematopoietic progenitor cell pool associated with bone marrow fibrosis for the support of autologous transplantation in IgD multiple myeloma.
    de la Serna J; Bornstein R; Lahuerta-Palacios JJ
    Bone Marrow Transplant; 1997 May; 19(10):1033-6. PubMed ID: 9169649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation.
    Patriarca F; Gaidano G; Capello D; Zaja F; Fanin R; Baccarani M
    Haematologica; 2000 Sep; 85(9):982-5. PubMed ID: 10980639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
    Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
    Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins.
    Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B
    Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of allografting with autografting for newly diagnosed myeloma.
    Bruno B; Rotta M; Patriarca F; Mordini N; Allione B; Carnevale-Schianca F; Giaccone L; Sorasio R; Omedè P; Baldi I; Bringhen S; Massaia M; Aglietta M; Levis A; Gallamini A; Fanin R; Palumbo A; Storb R; Ciccone G; Boccadoro M
    N Engl J Med; 2007 Mar; 356(11):1110-20. PubMed ID: 17360989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant.
    Radujkovic A; Hundemer M; Eisenbach C; Luft T; Penzel R; Goldschmidt H; Ho AD; Bellos F
    Leuk Lymphoma; 2014 Dec; 55(12):2967-9. PubMed ID: 24707945
    [No Abstract]   [Full Text] [Related]  

  • 76. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea.
    Woo YR; Kim JS; Lim JH; Hwang S; Kim M; Bae JM; Park YM; Min CK; Kim DW; Park HJ
    J Am Acad Dermatol; 2018 Mar; 78(3):471-478.e4. PubMed ID: 29107338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The current status of hematopoietic stem cell transplantation for multiple myeloma.
    Bensinger WI
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
    Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
    Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation.
    Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.